✦ LIBER ✦

Prediction of therapy response to interferon-alpha in chronic viral hepatitis-B by liver and hepatobiliary scintigraphy

✍ Scribed by Meltem Caglar; Oktay Sari; Yusuf Akcan

Publisher: Springer Japan
Year: 2002
Tongue: English
Weight: 560 KB
Volume: 16
Category: Article
ISSN: 0914-7187
DOI: 10.1007/bf02988654

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-alpha therapy for chronic hep

Interferon-alpha therapy for chronic hepatitis B: Early response related to pre-treatment changes in viral replication

✍ R.A. Heijtink; H.L.A. Janssen; W.C.J. Hop; A.D.M.E. Osterhaus; S.W. Schalm 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Patterns of viral decline during PEG-int

Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response

✍ Martijn J. ter Borg; Monika van Zonneveld; Stefan Zeuzem; Hakan Senturk; Ulus S. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 2 views

In chronic hepatitis B, it is difficult to predict an early therapeutic response. We investigated the viral decline during therapy with pegylated interferon alpha-2b (PEG-IFN) with or without lamivudine in 266 HBeAg-positive chronic hepatitis B patients. In patients treated with PEG-IFN and lamivudi

Prediction of response during interferon

Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison

✍ M J Tong; L M Blatt; J G McHutchison; R L Co; A Conrad 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

Patients with chronic hepatitis C (n Å 103) were treated cases of acute hepatitis C occur on an annual basis, and an estimated 8,000 to 10,000 deaths occur each year of compli-for 24 weeks with interferon alfa 2b and followed up for 24 weeks after cessation of therapy (week 48). When hepatitis catio

Analysis of clinical and virological fac

Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C

✍ Dr. J. A. Garson; K. Whitby; R. Deaville; S. Brillanti; M. Foli; C. Masci; M. Mi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

## Abstract Interferon alpha (IFN‐α) therapy is currently the treatment of choice for chronic hepatitis C (HCV) infection, but it fails to achieve a sustained response in approximately 75% of those treated. The factors which determine whether or not an individual will respond to IFN‐α are uncertain

Expression of transforming growth factor

Expression of transforming growth factor alpha in the liver before and after interferon alfa therapy for chronic hepatitis B

✍ Dr Yosuke Morimitsu; David E. Kleiner Jr.; Hari S. Conjeevaram; Chu Chieh Hsia; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

The effect of interferon alfa (IFN-a) therapy on the expression of transforming growth factor alpha (TGF-a) in the liver during chronic hepatitis B was investigated. Serial liver biopsy specimens were evaluated from 35 patients who had participated in a randomized, controlled trial of recombinant hu

Prediction of response to treatment of c

Prediction of response to treatment of chronic hepatitis B with pegylated interferon in the Philippines

✍ Dorothy M. Agdamag; Seiji Kageyama; Prisca S. Leaño; Rontgene M. Solante; Elizab 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 2 views

## Abstract The response marker for interferon has not been investigated fully for hepatitis B viruses (HBVs) in the Philippines where novel subtypes B5 and C5 were recognized recently. The prediction parameters for interferon treatment were assessed, with emphasis on the mutation patterns in the b